Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M203Revenue (TTM) $M--Net Margin (%)--Altman Z-Score2.3
Enterprise Value $M144EPS (TTM) $-3.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio7.4Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %7.4Current Ratio7.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-62.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-73.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.2ROIC % (ttm)-313.9Gross Margin Increase y-yN

Gurus Latest Trades with CASC

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CASC is held by these investors:



CASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myers Scott DunsethPresident and CEO 2017-03-31Buy2,000$4.111.46view
Fyfe Gwen A.Director 2017-03-28Buy1,666$4.121.21view
Myers Scott DunsethPresident and CEO 2017-03-20Buy1,000$3.936.11view
LOVE TED WDirector 2017-02-02Buy23,000$4.24-1.65view
HENNEY CHRISTOPHER SDirector 2017-01-30Buy25,324$4.111.46view
Myers Scott DunsethPresident and CEO 2017-01-27Buy20,500$3.7610.9view
Myers Scott DunsethPresident and CEO 2016-08-17Buy7,500$6.9-39.57view
Myers Scott DunsethPresident and CEO 2016-06-28Buy10,417$4.8-13.13view
HAUSMAN DIANAChief Medical Officer 2015-06-01Buy5,747$4.65-10.32view
SPIEGELMAN DANIEL KDirector 2015-03-26Buy20,000$1.61159.01view

Press Releases about CASC :

Quarterly/Annual Reports about CASC:

    News about CASC:

    Articles On GuruFocus.com
    Cascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for Apr 05 2017 
    Cascadian Therapeutics Announces Changes to Board of Directors Mar 13 2017 
    Cascadian Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results Mar 09 2017 
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics Jul 11 2016 
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 

    More From Other Websites
    Cascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for... Apr 05 2017
    Cascadian Therapeutics Announces Changes to Board of Directors Mar 13 2017
    Cascadian Therapeutics reports 4Q loss Mar 09 2017
    Cascadian Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results Mar 09 2017
    Cascadian Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference Feb 27 2017
    Should You Buy Alico, Inc. (ALCO)? Dec 20 2016
    Here’s What Smart Money Think about Jones Energy Inc (JONE) Dec 12 2016
    Do Hedge Funds Love Invuity, Inc. (IVTY)? Dec 10 2016
    Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc... Dec 08 2016
    Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards Dec 07 2016
    A Breast Cancer Drug That Gets In The Brain? Cascadian Sees A Way Forward Dec 07 2016
    Cascadian Therapeutics, Inc. :CASC-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 Dec 01 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)